The Exchange has sought clarification from Vanta Bioscience Ltd on February 25, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
By the next day the stock moved 18.3 pts less than Nifty Microcap 250 and 19.3 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
BSE has asked Vanta Bioscience Ltd to explain the reasons behind a significant movement in its share price, with the query dated February 25, 2026. This is a standard exchange procedure triggered when a stock shows unusual price activity, aimed at ensuring investors have the latest relevant information. The company is expected to respond with details about any corporate action, financial development, or material event that may have caused the price swing. Until the company replies, the reason behind the price movement remains unconfirmed. Shareholders should monitor the company's forthcoming response for clarity.
This is a routine regulatory query and does not by itself indicate any wrongdoing or negative event. Investors should wait for the company's clarification to understand what triggered the price move before making any decisions.